Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.79B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$576M |
| 3 |
Microsoft
MSFT
|
+$546M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$436M |
| 5 |
JPMorgan Chase
JPM
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$2.48B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.73B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$765M |
| 4 |
Apple
AAPL
|
+$656M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$526M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.7% |
| 2 | Consumer Discretionary | 1.66% |
| 3 | Financials | 1.18% |
| 4 | Communication Services | 1.07% |
| 5 | Healthcare | 0.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
PUT
J.M. Smucker
SJM
$14B
| $13.7M | ﹤0.01% |
93,100
-55,000
| -37% | -$8.39M |
|
|
ISEE
2102
CALL
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $13.7M | ﹤0.01% |
348,400
-39,400
| -10% | -$1.39M |
|
2103
CALL
DoubleVerify
DV
$2.06B
| $13.7M | ﹤0.01% |
352,000
+150,700
| +75% | +$4.86M |
|
2104
CALL
Krystal Biotech
KRYS
$10.6B
| $13.7M | ﹤0.01% |
116,600
+74,400
| +176% | +$7.6M |
|
2105
PUT
iQIYI
IQ
$948M
| $13.7M | ﹤0.01% |
2,562,500
+64,700
| +3% | +$364K |
|
2106
PUT
Virgin Galactic
SPCE
$438M
| $13.7M | ﹤0.01% |
176,170
+105,515
| +149% | +$8.36M |
|
2107
CALL
HF Sinclair
DINO
$17.2B
| $13.7M | ﹤0.01% |
306,100
+159,100
| +108% | +$6.93M |
|
2108
CALL
SBA Communications
SBAC
$19.7B
| $13.7M | ﹤0.01% |
58,900
-7,000
| -11% | -$1.67M |
|
|
AMED
2109
DELISTED
Amedisys
AMED
| $13.6M | ﹤0.01% |
149,239
+126,583
| +559% | +$10.4M |
|
2110
Idexx Laboratories
IDXX
$43.6B
| $13.6M | ﹤0.01% |
27,096
-23,096
| -46% | -$11.1M |
|
2111
ZipRecruiter
ZIP
$354M
| $13.6M | ﹤0.01% |
765,968
+532,206
| +228% | +$8.76M |
|
2112
iShares Semiconductor ETF
SOXX
$42B
| $13.6M | ﹤0.01% |
80,394
-119,322
| -60% | -$17.9M |
|
2113
PUT
CBRE Group
CBRE
$43.5B
| $13.6M | ﹤0.01% |
168,400
+108,400
| +181% | +$8.12M |
|
2114
PUT
Sweetgreen
SG
$815M
| $13.6M | ﹤0.01% |
1,059,700
+341,900
| +48% | +$3.16M |
|
2115
T. Rowe Price
TROW
$24B
| $13.6M | ﹤0.01% |
121,166
+8,328
| +7% | +$912K |
|
2116
CALL
Neurocrine Biosciences
NBIX
$15.9B
| $13.6M | ﹤0.01% |
143,800
+95,300
| +196% | +$9.31M |
|
2117
CALL
Welltower
WELL
$174B
| $13.5M | ﹤0.01% |
167,500
-138,500
| -45% | -$10.7M |
|
2118
American Electric Power
AEP
$67.2B
| $13.5M | ﹤0.01% |
160,860
-135,366
| -46% | -$12M |
|
2119
Madrigal Pharmaceuticals
MDGL
$12.5B
| $13.5M | ﹤0.01% |
58,398
-70,560
| -55% | -$19.1M |
|
2120
CALL
Sphere Entertainment
SPHR
$5.65B
| $13.5M | ﹤0.01% |
492,500
+414,600
| +532% | +$13.7M |
|
2121
CALL
Ameriprise Financial
AMP
$49.5B
| $13.5M | ﹤0.01% |
40,600
+2,400
| +6% | +$738K |
|
2122
PUT
Synchrony
SYF
$26B
| $13.5M | ﹤0.01% |
397,100
-303,100
| -43% | -$9.26M |
|
2123
PUT
Camtek
CAMT
$6.69B
| $13.5M | ﹤0.01% |
377,800
+130,400
| +53% | +$3.74M |
|
2124
iShares Biotechnology ETF
IBB
$10.8B
| $13.4M | ﹤0.01% |
105,863
-101,600
| -49% | -$13.2M |
|
2125
PUT
Edison International
EIX
$28.7B
| $13.4M | ﹤0.01% |
193,500
+145,200
| +301% | +$10.2M |
|
Similar funds
Jeff Yass's Q2 2023 Portfolio in Review
As of Q2 2023, Jeff Yass held 13,811 positions worth $492B, up 4.6% from $470B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jeff Yass's Q2 2023 filing shows 1,371 new, 4,862 increased, 5,559 reduced and 1,866 closed positions. Its largest new stake was State Street SPDR Portfolio Aggregate Bond ETF: 1,297,445 shares worth $32.9M. The largest sale was Invesco QQQ Trust, an estimated $2.48B.
By sector, the portfolio is most concentrated in Technology at 2.7% of assets, up from 2.3% a quarter earlier, followed by Consumer Discretionary and Financials.
- Jeff Yass's largest Q2 2023 buy was State Street SPDR Portfolio Aggregate Bond ETF: 1,297,445 shares worth $32.9M.
- Jeff Yass added most to NVIDIA in Q2 2023, an estimated $1.79B increase.
- Jeff Yass's biggest Q2 2023 reduction was Invesco QQQ Trust, cutting an estimated $2.48B.
- Jeff Yass fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q2 2023, selling an estimated $45.5M.
- Jeff Yass's ten largest holdings make up 30% of its $492B portfolio in Q2 2023.
- Jeff Yass opened 1,371 new positions and closed 1,866 in Q2 2023.
- Jeff Yass's portfolio value rose 4.6% quarter-over-quarter to $492B.
Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.